The fund primarily allocates its capital, typically committing a minimum of 80% of its net assets (plus any leverage utilized for investment purposes), to the constituent securities of its tracking index. This benchmark is specifically designed to encompass U. S. healthcare companies whose market valuations, at the time of index rebalancing, exceed that of the 1,001st largest American enterprise.